New techniques for sentinel node biopsy in breast cancer

Sentinel lymph node biopsy (SLNB) is still the standard of care for axillary nodal staging in patients with invasive breast cancer (BC) and clinically negative lymph nodes (LNs). It successfully replaced the more invasive and morbid axillary lymph node dissection (ALND). The actual standard for SLNB...

Full description

Bibliographic Details
Main Authors: Ferrucci, M, Franceschini, G, Douek, M
Format: Journal article
Published: AME Publishing Company 2018
_version_ 1826281590409396224
author Ferrucci, M
Franceschini, G
Douek, M
author_facet Ferrucci, M
Franceschini, G
Douek, M
author_sort Ferrucci, M
collection OXFORD
description Sentinel lymph node biopsy (SLNB) is still the standard of care for axillary nodal staging in patients with invasive breast cancer (BC) and clinically negative lymph nodes (LNs). It successfully replaced the more invasive and morbid axillary lymph node dissection (ALND). The actual standard for SLNB is the radioisotope (RI) with or without blue dye (BD) technique. Because of several drawbacks reported in worldwide experiences, new techniques have been developed in the last years: indocyanine green (ICG) fluorescence, superparamagnetic iron oxide (SPIO) nanoparticles and contrast-enhanced ultrasound (CEUS) using microbubbles. Whilst each technique has its own advantages/disadvantages they are increasing their efficacy and are candidate to represent a new standard for SLNB in next future. This is a comprehensive review of current limitations of conventional techniques besides the improvements and innovations of new methods which, anyway, need future randomized controlled trials to be fully validated.
first_indexed 2024-03-07T00:31:05Z
format Journal article
id oxford-uuid:7fd394f2-f7cc-4418-970a-58f04d77f6ed
institution University of Oxford
last_indexed 2024-03-07T00:31:05Z
publishDate 2018
publisher AME Publishing Company
record_format dspace
spelling oxford-uuid:7fd394f2-f7cc-4418-970a-58f04d77f6ed2022-03-26T21:19:20ZNew techniques for sentinel node biopsy in breast cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7fd394f2-f7cc-4418-970a-58f04d77f6edSymplectic Elements at OxfordAME Publishing Company2018Ferrucci, MFranceschini, GDouek, MSentinel lymph node biopsy (SLNB) is still the standard of care for axillary nodal staging in patients with invasive breast cancer (BC) and clinically negative lymph nodes (LNs). It successfully replaced the more invasive and morbid axillary lymph node dissection (ALND). The actual standard for SLNB is the radioisotope (RI) with or without blue dye (BD) technique. Because of several drawbacks reported in worldwide experiences, new techniques have been developed in the last years: indocyanine green (ICG) fluorescence, superparamagnetic iron oxide (SPIO) nanoparticles and contrast-enhanced ultrasound (CEUS) using microbubbles. Whilst each technique has its own advantages/disadvantages they are increasing their efficacy and are candidate to represent a new standard for SLNB in next future. This is a comprehensive review of current limitations of conventional techniques besides the improvements and innovations of new methods which, anyway, need future randomized controlled trials to be fully validated.
spellingShingle Ferrucci, M
Franceschini, G
Douek, M
New techniques for sentinel node biopsy in breast cancer
title New techniques for sentinel node biopsy in breast cancer
title_full New techniques for sentinel node biopsy in breast cancer
title_fullStr New techniques for sentinel node biopsy in breast cancer
title_full_unstemmed New techniques for sentinel node biopsy in breast cancer
title_short New techniques for sentinel node biopsy in breast cancer
title_sort new techniques for sentinel node biopsy in breast cancer
work_keys_str_mv AT ferruccim newtechniquesforsentinelnodebiopsyinbreastcancer
AT franceschinig newtechniquesforsentinelnodebiopsyinbreastcancer
AT douekm newtechniquesforsentinelnodebiopsyinbreastcancer